These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15747280)

  • 1. New pharmacologic approaches for the perioperative treatment of ischemic cardiogenic shock.
    Lehmann A; Boldt J
    J Cardiothorac Vasc Anesth; 2005 Feb; 19(1):97-108. PubMed ID: 15747280
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy of cardiogenic shock. Improvement in hemodynamics is essential].
    Stiefelhagen P
    Med Monatsschr Pharm; 2010 Aug; 33(8):303-5. PubMed ID: 21189650
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiogenic shock].
    Houegnifioh KK; Gfeller E; Garcia W; Ribordy V
    Rev Med Suisse; 2014 Aug; 10(438):1495-500. PubMed ID: 25199224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based use of levosimendan in different clinical settings.
    De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
    Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy of cardiogenic shock.
    Barrett AM
    Int J Clin Pharmacol; 1973 Apr; 7(2):105-8. PubMed ID: 4731278
    [No Abstract]   [Full Text] [Related]  

  • 6. Levosimendan in cardiogenic shock: the magic drug for every patient?
    Smetana P; Geppert A
    Crit Care Med; 2007 Dec; 35(12):2862-4. PubMed ID: 18043208
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stimulating and hypobiotic therapy in cardiogenic shock].
    Bobrov VA; Shved NI; Sherman DM
    Lik Sprava; 1994; (5-6):7-12. PubMed ID: 7831916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiogenic shock in myocardial infarction: revascularization, mechanical support and pharmacotherapy].
    Buerke M; Russ M; Werdan K
    Dtsch Med Wochenschr; 2008 Nov; 133(48):2516-21. PubMed ID: 19021085
    [No Abstract]   [Full Text] [Related]  

  • 9. Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.
    García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ
    J Clin Pharmacol; 2005 Jun; 45(6):704-8. PubMed ID: 15901754
    [No Abstract]   [Full Text] [Related]  

  • 10. Inotropes.
    Francis GS; Bartos JA; Adatya S
    J Am Coll Cardiol; 2014 May; 63(20):2069-2078. PubMed ID: 24530672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inotropic agents in the treatment of cardiogenic shock.
    Mueller HS
    World J Surg; 1985 Feb; 9(1):3-10. PubMed ID: 3885584
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of cardiogenic shock: focus on tissue perfusion.
    den Uil CA; Lagrand WK; Valk SD; Spronk PE; Simoons ML
    Curr Probl Cardiol; 2009 Aug; 34(8):330-49. PubMed ID: 19591748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction].
    Arias EA; González-Chon O; García-López SM; Chacón MA; Noriega-Iriondo F; Vega RE; Chávez-Tapia NC
    Arch Cardiol Mex; 2005; 75(3):260-6. PubMed ID: 16294814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative pharmacologic cardioprotection and sodium hydrogen ion exchange inhibitors: one step forward and two steps back?
    London MJ; Henderson WG
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):565-9. PubMed ID: 16202887
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of cardiogenic shock.
    Dack S
    N Y State J Med; 1973 Jul; 73(14):1894-6. PubMed ID: 4581719
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial injury and its prevention in the perioperative setting.
    Zaugg M; Schaub MC; Foëx P
    Br J Anaesth; 2004 Jul; 93(1):21-33. PubMed ID: 15145824
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiogenic shock.
    Krost WS
    Emerg Med Serv; 2004 Sep; 33(9):69-73, 78. PubMed ID: 15481660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan reversing low output syndrome after heart transplantation.
    Petäjä LM; Sipponen JT; Hämmäinen PJ; Eriksson HI; Salmenperä MT; Suojaranta-Ylinen RT
    Ann Thorac Surg; 2006 Oct; 82(4):1529-31. PubMed ID: 16996977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of inotropes in cardiogenic shock: to help, to harm or do nothing at all?
    Lepage-Ratte MF; Hibbert B; Mathew R
    Eur Heart J Cardiovasc Pharmacother; 2024 Feb; 10(2):98-99. PubMed ID: 38081223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.